期刊文献+

脂肪酸合成酶在膀胱移行细胞癌组织中的表达及其临床意义 被引量:3

Expression of fatty acid synthase in bladder transitional cell carcinoma and its significance
下载PDF
导出
摘要 背景与目的:脂肪酸合成酶(fatty acid synthase,FAS)是一种新的肿瘤标志物,高表达常提示肿瘤的预后不良,由此本文旨在研究膀胱移行细胞癌中的表达及其临床意义。方法:对65例随访5年的膀胱移行细胞癌手术患者的石蜡标本进行FAS的免疫组织化学染色分析,并与15例正常膀胱粘膜组织进行对照。结果:与正常组织相比,FAS在膀胱移行细胞癌组织中高表达,阳性表达率58.5%(38/65),差异有显著性(P<0.05)。FAS的表达与肿瘤分级、初发、复发有关(P<0.05),但与临床分期及肿瘤数目无关。FAS阳性表达患者的5年生存率远低于阴性患者(18%vs.44%),差异有显著性(P<0.05)。结论:FAS在膀胱移行细胞癌组织中表达增高,酶活性增强;FAS在膀胱移行细胞癌组织中表达增高有提示不良预后的作用。 Background and purpose: Fatty acid synthase(FAS) is a new tumor marker, the high expression of which has been reported to be associated with poor prognosis of cancer patients. This study investigated the expression of FAS in transitional cell carcinoma (TCC) of bladder and its elinical significance. Methods: The expressions of FAS were detected by streptavidin-peroxidase innnonohistochemieal method in the paraffin embedded sections of 65 TCC patients and the clinical data had been reviewed. 15 normal bladder tissues were used as control group. Results: The positive rate of the expression of FAS in TCC was 58.5% (38/65), while only 2 of 15 cases in control group expressed FAS protein. The difference was statistically significant, the expression of FAS was related to the histological grades and recurrence but not different pathological stages. Survival analysis revealed that the 5-yr survival rate was lower in FAS positive patients than in negative patients ( 18% vs. 44%, P 〈0.05). Conclusions: Fatty acid synthase is ore,expressed in TCC of bladder and might serve as a biomarker tor the poor prognosis of the patients.
出处 《中国癌症杂志》 CAS CSCD 2007年第5期395-397,共3页 China Oncology
关键词 膀胱移行细胞癌 脂肪酸合成酶 预后 bladder transitional cell carcinoma fatty acid synthase prognosis
  • 相关文献

参考文献12

  • 1Pizer ES,Thupari J,Han WF,et al.Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cells and xenografts[J].Cancer Res,2000,60:213-218.
  • 2Hennigar RA,Pochet M,Hunt DA,et al.Characterization of fatty acid synthase in cell linesderived from experimental mammary tumors[J].Biochim Biophy Acta,2005,1392:185-199.
  • 3Yang YA,Han WF,Morin PJ,et al.Activation of fatty acid synthesis during neoplastic transformation:role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase[ J ].Exp Cell Res,2002,279(1):80-90.
  • 4Rossi S,Graner E,Feb.P,et al.Fatty acid synthase expression defines distinct molecular signatures in prostate cancer[ J ].Mol Cancer Res,2003,1 (10):707-715.
  • 5Pizer E.S Lax SF Kuhajda FP,et al.Fatty acid synthase expression in endometrial carcinoma:correlation with cell proliferation and hormone receptors[J].Cancer,1998,83 (3):528-537.
  • 6Pizer ES,Wood FD,Pasternack GR,et al.Fatty acid synthase (FAS):a target for cytotoxic anti-metabolites in HL60 promyelocytic leukemia cells[J].Cancer Res,1996,56(4):745-751.
  • 7Dunphy JT,Linder ME.Signalling functions of protein palmitoylation[J].Biochim Biophys Acta,1998,1436 (122):245-261.
  • 8Alo PL,Visca P,Trombetta G,et al.Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas[J].Tumori,1999,85:35-40.
  • 9Pizer ES,Thupari J,Han WF,et al.Malonyl-coenzyme-A is a potential mediator of cyto-toxicity induced by fatty acid synthase inhibition in human breast cells and xenografts[ J ].Cancer Res,2000,60:213-218.
  • 10Pizer ES,Lax SF,Kuhajda FP,et al.Fatty acid synthase expression in endometrial carcinoma:correlation with cell proliferation and hormone receptors[J].Cancer,1998,83:528-537.

同被引文献49

  • 1Schajowicz F,Sissons H A,Sobin L H. The World Health Organization's Histologie Classification of Bone Tumors. A Commentary on the Second Edition[J]. Cancer, 1995,75(5) : 1208- 1214.
  • 2Kuhajda F P,Piantadosi S,Pasternack G R. Haptoglobin-related Protein (Hpr) Epitopes in Breast Cancer as a Predictor of Recurrence of the Disease[J]. N Engl J Med, 1989,321 (10) : 636-641.
  • 3Wang Y, Kuhajda F P, Li J N, et al. Fatty Acid Synthase (FAS) Expression in Human Breast Cancer Cell Culture Supernatants and in Breast Cancer Patients[J].Cancer Lett, 2001,167(1) : 99-104.
  • 4Innocenzi D,AIo P L,Balzani A,et al. Fatty Acid Synthase Expression in Melanoma[J]. J Cutan Pathol, 2003,30(1) : 23-28.
  • 5Camassei F D, Cozza R, Acquaviva A, et a l. Expression of the Lipogenic Enzyme Fatty Acid Synthase (FAS) in Retinoblastoma and its Correlation with Tumor Aggressiveness[J]. Invest Ophthalmol Vis Sci, 2003,44 (6) : 2399-2403.
  • 6Pflug B R,Pecher S M,Brink A W,et al. Increased Fatty Acid Synthase Expression and Activity During Progression of Prostate Cancer in the TRAMP Model[J]. Prostate, 2003,57 (3): 245-254.
  • 7Tsuji T, Yoshinaga M, Togami S,et al. Fatty Aid Snthase Expression and Clinicopathological Findings in Endometrial Cancer[J]. Acta-Obstet Gynecol Scand,2004,83(6) :586-590.
  • 8Swinnen J V, Roskams T, Joniau S, et al. Overexpression of Fatty Acid Synthase is an Early and Common Event in the Development of Prostate Cancer [J].Int J Cancer, 2002,98 (1) : 19-22.
  • 9Pizer E S,Pflug B R,Bova G S,et al. Increased Fatty Acid Synthase as a Therapeutic Target in Androgen-independent Prostate Cancer Progression[J]. Prostate,2001,47(2) : 102-110.
  • 10Van de Sande T,De Schrijver E, Heyns W,et al. Role of the Phosphatidylinositol 3' Kinase/PTEN/Akt Kinase Pathway in the Overexpression of Fatty Acid Synthase in LNCaP Prostate Cancer Cells[J].Cancer Research,2002,62(3):642-646.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部